Srs Capital Advisors, Inc. Xencor Inc Transaction History
Srs Capital Advisors, Inc.
- $1.48 Billion
- Q1 2025
A detailed history of Srs Capital Advisors, Inc. transactions in Xencor Inc stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 9 shares of XNCR stock, worth $77. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9
Previous 485
98.14%
Holding current value
$77
Previous $11,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding XNCR
# of Institutions
210Shares Held
78.4MCall Options Held
3.4KPut Options Held
1.9K-
Black Rock Inc. New York, NY11.1MShares$95.3 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.76MShares$83.7 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$67.8 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$52.7 Million5.14% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$33.7 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $512M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...